New investigational treatment in migraine prevention

This is a placebo controlled trial to test the efficacy and safety of daily oral Atogepant in the prevention of episodic migraine. The study will consist of a 4-week screening period, a 12-week treatment period, and a 4-week follow up period for a total duration of 20 weeks. After completion of the lead-in study there is an option to roll into a 9-month open label study.

Subjects must be between 18-80 years old and have at least 4 migraine headache days per month, but no more than 14 headache days a month. Subjects must have tried at least one preventative medication, although cannot currently be using a preventative medication. Use of migraine abortive medications is allowed throughout the study.

Subjects may

Reputable Canadian Online Pharmacies, Overstock Drugstore clomid men buy clomid online Canadian Mail Order Pharmacies, clomid success rate by age Online Pharmacy Generic

receive up to $800 for their participation. All study medication and procedures will be provided at no cost to the participants.